Pharm
Antiviral Medication
search
Antiviral Medication
, Antiviral Agent, Antiviral Drug, Antiviral
See Also
Viral Infection
Anti-Retroviral Therapy
Hepatitis C Antiviral Regimen
Mechanism
Virus
es lack the easy targets of
Antibiotic
s (e.g. cell membranes, peptidoglycan cell walls, ribosomes)
Virus
es have only a few potential targets for Antivirals
Viral capsid (
Protein
coat)
Nucleic Acid
s
Enzymes for replication
Most Antivirals target replication steps
Results in virustatic agents that suppress replication, but do not kill the virus
Viable virus remains in latent state
Most common Antiviral mechanism is as
Nucleotide
analogues
Act as non-functional decoys competitively binding viral replication enzymes
Some are incorporated into DNA, resulting in non-functional enzyme
Protein
s
Medications
Herpesvirus
Antivirals -
Nucleic Acid
Polymerase Inhibitors (DNA or RNA)
See
Herpesviridae
See
Herpes Simplex Virus
(HSV)
See
Varicella Zoster Virus
(VZV)
See
Cytomegalovirus
(CMV)
Synthetic
Nucleoside
analogues (e.g.
Acyclovir
,
Famciclovir
,
Valacyclovir
,
Ganciclovir
)
Acyclovir
,
Famciclovir
,
Valacyclovir
are indicated for
Varicella Zoster Virus
and
Herpes Simplex Virus
Infections
Ganciclovir
and Valgancyclovir have greater activity against CMV and EBV (used in
AIDS
and BMT patients)
Agents are prodrugs metabolized by multiple enzymes (esp. thymidine kinase) to active triphosphate drug
These prodrugs require thymidine kinase for actvity
Famciclovir
and
Valacyclovir
reach higher drug levels after oral ingestion than
Acyclovir
Famciclovir
and
Valacyclovir
lack the protential nephrotoxicity of IV
Acyclovir
Thymidine kinase phosphorylates these prodrugs into their active form
Thymidine kinase is found in
Herpesviridae
, but not in humans
Acyclovir
,
Famciclovir
and
Valacyclovir
are only active only when Herpes viruses are present
Some strains of CMV do not carry Thymidine kinase
Results in Antiviral resistance
Pyrophosphate analog -
DNA Polymerase
Inhibitor (e.g.
Foscarnet
)
Foscarnet
is a synthetic analog of inorganic pyrophosphate
Selectively blocks viral
DNA Polymerase
s at their pyrophosphate binding site, preventing
DNA Replication
Indicated in
CMV Retinitis
and HSV infection in
Immunocompromised
patients
Phosphonate
Nucleoside
analog -
DNA Polymerase
Inhibitor (e.g.
Cidofovir
)
Active against the
Herpes Family of Viruses
, especially
Cytomegalovirus
(CMV).
Synthetic, acyclic, monophosphate
Nucleotide
analog of deoxycytidine (deoxyribonucleoside in DNA synthesis)
Cidofovir
is activated within infected host cells, via phosphorylation by pyruvate kinases to
Cidofovir
diphosphate
Cidofovir
diphosphate competes with deoxycytosine-5-triphosphate (dCTP) for viral
DNA Polymerase
When incorporated into DNA, it prevents viral DNA polymerization, blocking viral
DNA Replication
Medications
HIV Antiviral Agents
See
Anti-Retroviral Therapy
See
HIV Pathophysiology
Host Cell fusion and penetration inhibitors
Fusion Inhibitor
s (e.g.
Enfuvirtide
)
Blocks HIV fusion to cell anchor
Protein
s
CCR5 Inhibitors (
Maraviroc
)
Block HIV binding at CCR5 co-receptor
CD4 Coreceptors (CCR5 or CXCR4) must be present on the host cell surface for HIV penetration
Nucleic Acid
Polymerase Inhibitors (DNA or RNA)
Nucleoside Reverse Transcriptase Inhibitor
(
nRTI
, e.g.
Tenofovir
,
Emtricitabine
,
Lamivudine
,
Zidovudine
)
Anti-Retroviral Therapy
for
HIV Infection
Non-Nucleoside Reverse Transcriptase Inhibitor
(
NNRTI
, e.g.
Efavirenz
,
Nevirapine
,
Doravirine
,
Etravirine
,
Rilpivirine
)
Anti-Retroviral Therapy
for
HIV Infection
Protease Inhibitor
s (e.g.
Atazanavir
,
Darunavir
,
Fosamprenavir
,
Indinavir
,
Ritonavir
,
Saquinavir
)
Anti-Retroviral Therapy
for
HIV Infection
Hepatitis C Antiviral Regimen
Covid19
Integrase Inhibitor
s (e.g.
Bictegravir
,
Cabotegravir
,
Dolutegravir
,
Raltegravir
)
Anti-Retroviral Therapy
for
HIV Infection
Medications
Other Antiviral Agents
Additional Antivirals are targeted at the infected host cell factors
Nucleic Acid
Polymerase Inhibitors (DNA or RNA)
NS5B Polymerase Inhibitors (e.g.
Sofosbuvir
) or NS5A Inhibitors (e.g. Velpatasvir)
Hepatitis C Antiviral Regimen
RdRP polymerase Inhibitor (e.g. Remdesivir)
Covid19
Viral Hemorrhagic Fever
(e.g.
Ebola Virus
,
Marburg Hemorrhagic Fever
)
Protease Inhibitor
s (e.g.
Atazanavir
,
Darunavir
,
Fosamprenavir
,
Indinavir
,
Ritonavir
,
Saquinavir
)
Anti-Retroviral Therapy
for
HIV Infection
Hepatitis C Antiviral Regimen
Covid19
Neuraminidase Inhibitor
(e.g.
Oseltamivir
)
Influenza
Infection
References
Kausar (2021) Int J Immunopathol Pharmacol 35:20587384211002621 +PMID: 33726557 [PubMed]
Peng (2022) Molecules 27(21):7370 +PMID: 36364196 [PubMed]
Type your search phrase here